Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh

• Emiliano Lucero ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliations Institute of Tropical Medicine and International Health, Charité—Universitätsmedizin Berlin, Germany, Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis—Universidad Nacional de Cordoba, Argentina

  ⨯
• Simon M. Collin ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation School of Social & Community Medicine, University of Bristol, United Kingdom

  ⨯
• Sujit Gomes ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation Médecins Sans Frontières, Fulbaria, Bangladesh

  ⨯
• Fatima Akter ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation Médecins Sans Frontières, Fulbaria, Bangladesh

  ⨯
• Asaduzzam Asad ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation Médecins Sans Frontières, Fulbaria, Bangladesh

  ⨯
• Asish Kumar Das ,

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation Médecins Sans Frontières, Fulbaria, Bangladesh

  ⨯
• Koert Ritmeijer

  * E-mail: koert.ritmeijer@amsterdam.msf.org

  ¶‡ EL, SMC, KR contributed equally to this work. SG, FA, AA, and AKD also contributed equally to this work.

  Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands

  ⨯